These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31677110)

  • 1. Twenty Clinically Pertinent Factors/Observations for Percutaneous Absorption in Humans.
    Law RM; Ngo MA; Maibach HI
    Am J Clin Dermatol; 2020 Feb; 21(1):85-95. PubMed ID: 31677110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anatomical location on
    Bormann JL; Maibach HI
    Cutan Ocul Toxicol; 2020 Sep; 39(3):213-222. PubMed ID: 32643443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shaving effects on percutaneous penetration: clinical implications.
    Hamza M; Tohid H; Maibach H
    Cutan Ocul Toxicol; 2015; 34(4):335-43. PubMed ID: 25363065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modest but increased penetration through damaged skin: an overview of the in vivo human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2011; 24(1):2-9. PubMed ID: 20588085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related percutaneous penetration part 1: skin factors.
    Konda S; Meier-Davis SR; Cayme B; Shudo J; Maibach HI
    Skin Therapy Lett; 2012 May; 17(5):1-5. PubMed ID: 22622279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced absorption through damaged skin: an overview of the in vitro human model.
    Gattu S; Maibach HI
    Skin Pharmacol Physiol; 2010; 23(4):171-6. PubMed ID: 20185974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tape-stripping technique as a method for drug quantification in skin.
    Escobar-Chávez JJ; Merino-Sanjuán V; López-Cervantes M; Urban-Morlan Z; Piñón-Segundo E; Quintanar-Guerrero D; Ganem-Quintanar A
    J Pharm Pharm Sci; 2008; 11(1):104-30. PubMed ID: 18445368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling the human skin barrier--towards a better understanding of dermal absorption.
    Jepps OG; Dancik Y; Anissimov YG; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):152-68. PubMed ID: 22525516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin metabolism in transdermal therapeutic systems.
    Hikima T; Tojo K; Maibach HI
    Skin Pharmacol Physiol; 2005; 18(4):153-9. PubMed ID: 15908755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breaking the skin barrier: achievements and future directions.
    Zhang H; Zhai Y; Yang X; Zhai G
    Curr Pharm Des; 2015; 21(20):2713-24. PubMed ID: 25925124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated human and animal stratum corneum as a partial model for the 15 steps of percutaneous absorption: emphasizing decontamination, part II.
    Hui X; Lamel S; Qiao P; Maibach HI
    J Appl Toxicol; 2013 Mar; 33(3):173-82. PubMed ID: 23112095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical penetration enhancers: a patent review.
    Ahad A; Aqil M; Kohli K; Chaudhary H; Sultana Y; Mujeeb M; Talegaonkar S
    Expert Opin Ther Pat; 2009 Jul; 19(7):969-88. PubMed ID: 19552513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico prediction of percutaneous absorption and disposition kinetics of chemicals.
    Chen L; Han L; Saib O; Lian G
    Pharm Res; 2015 May; 32(5):1779-93. PubMed ID: 25407547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential oils and their constituents as skin penetration enhancer for transdermal drug delivery: a review.
    Herman A; Herman AP
    J Pharm Pharmacol; 2015 Apr; 67(4):473-85. PubMed ID: 25557808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical and Transdermal Delivery of Drug-Loaded Nano/ Microsystems with Application of Physical Enhancement Techniques.
    Borgheti-Cardoso LN; Ângelo T; Gelfuso GM; Lopez RF; Gratieri T
    Curr Drug Targets; 2016; 17(13):1545-59. PubMed ID: 26477464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defense against dermal exposures is only skin deep: significantly increased penetration through slightly damaged skin.
    Nielsen JB; Nielsen F; Sørensen JA
    Arch Dermatol Res; 2007 Nov; 299(9):423-31. PubMed ID: 17882442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical and pharmacokinetic modelling of epidermal and dermal transport processes.
    Anissimov YG; Jepps OG; Dancik Y; Roberts MS
    Adv Drug Deliv Rev; 2013 Feb; 65(2):169-90. PubMed ID: 22575500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metrics and clinical relevance of percutaneous penetration and lateral spreading.
    Vieille-Petit A; Blickenstaff N; Coman G; Maibach H
    Skin Pharmacol Physiol; 2015; 28(2):57-64. PubMed ID: 25227720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a compounding phospholipid base for the percutaneous absorption of high molecular weight drugs using the Franz finite dose model.
    Banov D; Song G; Carvalho M; Bassani AS; Valdez BC
    Skin Res Technol; 2024 Feb; 30(2):e13610. PubMed ID: 38352988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.